Menu
OncoHost is a newly established company developing personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, we aim to understand the patient’s unique response to therapy to overcome one of the major obstacles in clinical oncology today – resistance to therapy.
OncoHost’s technology is based on machine learning generated analysis of the pro-tumorigenic processes induced by the body’s response to cancer treatments. We discover new targets that may be combined with current, standard-of-care, treatments to increase responsiveness.
© 2021 StartupHub.ai. All rights reserved.